Tissue evaluation for neurotrophins in the intestinal tissue denoted that an axis between CNS-inflammatory-activated response following NTG-induced migraine and the intestinal functionality exists and could be simultaneously targeted by SCFAs. The gene discussed is BDNF; the disease is migraine disorder.